Tirzepatide and NAD+ Together: Metabolic Health

Last reviewed: June 6, 2026

Last updated: June 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

The combination of tirzepatide—a dual GLP-1 and GIP receptor agonist—with NAD+ supplementation represents an emerging area of metabolic optimization. Both compounds influence cellular energy pathways, but whether taking them together amplifies weight loss or creates unwanted interactions remains an important clinical question. PlexusDx helps patients understand how medication combinations affect their individual metabolic profile through personalized genetic insights.

How Tirzepatide and NAD+ Affect Cellular Metabolism Differently

Tirzepatide works by activating GLP-1 and GIP receptors in the brain and gut, reducing appetite, slowing stomach emptying, and improving insulin sensitivity. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme that powers mitochondrial energy production and supports DNA repair pathways. While tirzepatide targets hunger signaling and glucose control, NAD+ addresses the energy currency inside cells—making them mechanistically distinct targets.

Research shows that NAD+ levels naturally decline with age, contributing to metabolic slowdown and reduced mitochondrial function. Some patients take NAD+ precursors (like NMN or NR) hoping to boost energy during weight loss, when calorie restriction can feel draining. Tirzepatide reduces hunger so patients eat less, which might theoretically benefit from cellular energy support—but this synergy has not been formally tested in clinical trials.

What Clinical Evidence Says About Combining These Compounds

No randomized controlled trials have directly studied tirzepatide plus NAD+ supplementation in humans. The evidence base for NAD+ boosters alone is mixed: some studies suggest NMN or NR improve insulin sensitivity and muscle function in animal models, but human trials show modest effects on weight loss or metabolic rate. When combined with tirzepatide's proven 20% average body weight reduction, adding NAD+ is largely uncharted territory.

The strongest clinical data for tirzepatide comes from the SURMOUNT trials, which demonstrated sustained weight loss and cardiometabolic benefits without requiring NAD+ supplementation. This suggests tirzepatide's effects on appetite, glucose, and weight are sufficient for meaningful change in most patients. NAD+ may offer quality-of-life support (energy, cognition) but should not be viewed as necessary for tirzepatide efficacy.

Potential Safety Considerations When Combining Tirzepatide With NAD+

Tirzepatide may lower blood sugar in people with prediabetes or diabetes, requiring medication adjustment. NAD+ boosters do not typically lower glucose, but combining them means patients must monitor blood sugar more carefully if they adjust their regimen. No known direct drug-supplement interaction exists between tirzepatide and NAD+ precursors (NMN, NR, or nicotinamide), but both affect mitochondrial function—patients with rare mitochondrial disorders should consult their doctor.

Gastrointestinal side effects from tirzepatide (nausea, constipation) are common during titration. NAD+ supplements do not cause GI upset in most people, but adding any supplement during tirzepatide adjustment can make it harder to identify which agent is causing discomfort. Starting tirzepatide alone, waiting for tolerance, then considering NAD+ later is a more thoughtful approach than combining them immediately.

Personalizing Your Metabolic Strategy With PlexusDx

PlexusDx offers compounded tirzepatide injection starting at $249/month with no insurance required, available in all 50 states. Beyond the medication itself, PlexusDx provides the Precision Peptide Genetic Test ($99 add-on after first month), which maps 14 metabolic pathways including mitochondrial energy genes. Testing variants in genes like GIPR and GLP1R helps predict how your body will respond to tirzepatide and whether supplemental metabolic support (like NAD+) aligns with your genetic predispositions.

If you are interested in exploring NAD+ with tirzepatide, PlexusDx clinicians can review your genetic profile and metabolic markers to determine if combination therapy makes sense for your situation. Rather than following a one-size-fits-all approach, precision health uses your individual biology to guide decisions—ensuring you invest in compounds that actually address your metabolic bottlenecks.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is it safe to take tirzepatide and NAD+ supplements at the same time?

No known direct interaction exists between tirzepatide and NAD+ precursors like NMN or NR. However, because both affect mitochondrial function and energy metabolism, monitoring for side effects is wise. Start tirzepatide alone first, allow your body to adjust for several weeks, and then discuss NAD+ supplementation with your healthcare provider if you feel persistent fatigue during weight loss.

Will NAD+ boost the weight loss results of tirzepatide?

There is no clinical evidence that NAD+ supplementation enhances tirzepatide-induced weight loss. Tirzepatide alone delivered approximately 20% body weight reduction in clinical trials. NAD+ may support energy and mitochondrial health during calorie restriction, but it is not proven to amplify appetite suppression or glucose control—the mechanisms driving tirzepatide's weight loss effect.

How much does tirzepatide cost at PlexusDx, and is NAD+ covered?

PlexusDx compounded tirzepatide injection starts at $249/month with no insurance required, no membership fee, and HSA/FSA eligibility. NAD+ supplements are not part of PlexusDx offerings; patients source them separately. Your dose of tirzepatide may increase over time, but your monthly price remains flat—your dose goes up, your price won't.

Can the Precision Peptide Genetic Test predict how I'll respond to NAD+?

PlexusDx Precision Peptide Genetic Test identifies variants in 14 metabolic pathways and 150+ genetic insights related to peptide hormones and glucose metabolism—not NAD+ metabolism specifically. The test maps variants in GIPR, GLP1R, FTO, and MC4R to personalize tirzepatide response. While it does not predict NAD+ efficacy, it helps confirm whether your genetic profile suggests you will benefit most from tirzepatide alone or if supplemental metabolic support aligns with your biology.

What should I do if I want to try NAD+ alongside tirzepatide from PlexusDx?

Discuss your interest in NAD+ supplementation with your PlexusDx clinician or primary care doctor before starting. Establish a baseline on tirzepatide first, then add NAD+ if energy or mitochondrial support feels necessary. PlexusDx clinicians can review your genetic test results and metabolic markers to advise whether combination therapy fits your personalized treatment plan.

Can You Take Tirzepatide and NAD+ Together? Exploring Synergistic Weight Loss and Metabolic Health